PAE: a new option for men with enlarged prostate
NICE heralds the approval of prostate artery embolism (PAE) as a safe and efficacious option for men with lower urinary tract symptoms symptoms secondary to benign prostatic hyperplasia (https://www.nice.org.uk/news/article/a-new-option-for-men-with-enlarged-prostate).
Nigel Hacking, who led the NICE, BAUS and BSIR sponsored ROPE study, welcomes this new guidance and thanks all the urologists and interventional radiologists from around the UK who worked hard to gain the evidence required to confirm that the results achieved from overseas single centre studies could be replicated by many in this first multicentre registry.
PAE can provide a bridge, along with Urolift for men not ready for prostate resection whether by laser or more traditional TURP.
NICE is keen to point out that the procedure is complex, and requires the specific skills of an interventional radiologist with additional training. PAE patients should be seen both by an interventional radiologist and a urologist, and selection should be made by this team – which really does offer men an increased choice.
The National press furore surrounding the release of these latest guidelines will undoubtedly lead to a lot of requests for PAE. The ROPE co-sponsors BAUS and BSIR will need to take a lead when re-writing their current guidelines and directing men to existing PAE Prostate Centres, and supporting the further education and training of interventional radiologists and urologists.
Read Dr Hacking’s article – Prostate artery embolization: ready for adoption?
What are your thoughts? What impact will the NICE approval have? Leave a comment below.